Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
250 GBX | 0.00% | +26.58% | -18.03% |
May. 03 | Kelso raises stake in NCC; Transense joins project | AN |
Apr. 30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
Sales 2024 * | 14.4M 15.66M | Sales 2025 * | 39.09M 42.51M | Capitalization | 210M 229M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.53M | Net income 2025 * | -4M -4.35M | EV / Sales 2024 * | 16.7 x |
Net Debt 2024 * | 30.6M 33.28M | Net cash position 2025 * | 42.27M 45.97M | EV / Sales 2025 * | 4.3 x |
P/E ratio 2024 * |
-9.53
x | P/E ratio 2025 * |
-18.8
x | Employees | 34 |
Yield 2024 * |
0.51% | Yield 2025 * |
-
| Free-Float | 60.71% |
Latest transcript on Faron Pharmaceuticals Oy
1 week | +26.58% | ||
Current month | +72.41% | ||
1 month | +112.77% | ||
3 months | +48.81% | ||
6 months | -5.66% | ||
Current year | -18.03% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 02-12-31 | |
Chairman | 60 | 23-03-23 | |
Founder | 46 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 250 | 0.00% | 33,416 |
24-05-16 | 250 | +4.17% | 59,690 |
24-05-15 | 240 | +6.67% | 16,310 |
24-05-14 | 225 | +4.65% | 21,232 |
24-05-13 | 215 | +8.86% | 81,035 |
Delayed Quote London S.E., May 17, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.03% | 229M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- FARN Stock